Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue

References

• Kalderon B, Mayorek N, Berry E, Zevit N, Bar-Tana J. Fatty acid cycling in the fasting rat. Am J Physiol Endocrinol Metab. 2000;279(1):E221–E227. doi:10.1152/ajpendo.2000.279.1.E221
   PubMedGoogle Scholar
• Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133–2223. doi:10.1152/physrev.00063.2017
   PubMed Web of Science ®Google Scholar
• Coleman RA, Mashek DG. Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling. Chem Rev. 2011;111(10):6359–6386. doi:10.1021/cr100404w
   PubMed Web of Science ®Google Scholar
• Kim C, Xuong NH, Taylor SS. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA. Science. 2005;307(5710):690–696. doi:10.1126/science.1104607
   PubMedGoogle Scholar
• Perea A, Clemente F, Martinell J, Villanueva-Penacarrillo ML, Valverde I. Physiological effect of glucagon in human isolated adipocytes. Horm Metab Res. 1995;27(8):372–375. doi:10.1055/s-2007-979981
   PubMedGoogle Scholar
• Miyoshi H, Souza SC, Zhang HH, et al. Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J Biol Chem. 2006;281(23):15837–15844. doi:10.1074/jbc.M601097200
   PubMed Web of Science ®Google Scholar
• Martinez-Botas J, Anderson JB, Tessier D, et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet. 2000;26(4):474–479. doi:10.1038/82630
   PubMed Web of Science ®Google Scholar
• Miyoshi H, Souza SC, Endo M, et al. Perilipin overexpression in mice protects against diet-induced obesity. J Lipid Res. 2010;51(5):975–982. doi:10.1194/jlr.M002352
   PubMedGoogle Scholar
• Itabe H, Yamaguchi T, Nimura S, Sasabe N. Perilipins: a diversity of intracellular lipid droplet proteins. Lipids Health Dis. 2017;16(1):83. doi:10.1186/s12944-017-0473-y
   PubMedGoogle Scholar
• Sahu-Osen A, Montero-Moran G, Schittmayer M, et al. CGI-58/ABHD5 is phosphorylated on Ser239 by protein kinase A: control of subcellular localization. J Lipid Res. 2015;56(1):109–121. doi:10.1194/jlr.M055004
   PubMedGoogle Scholar
• Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab. 2009;297(2):E289–E296. doi:10.1152/ajpendo.00099.2009
   PubMed Web of Science ®Google Scholar
• Lass A, Zimmermann R, Haemmerle G, et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in chanarin-dorfman syndrome. Cell Metab. 2006;3(5):309–319. doi:10.1016/j.cmet.2006.03.005
   PubMed Web of Science ®Google Scholar
• Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004;306(5700):1383–1386. doi:10.1126/science.1100747
   PubMed Web of Science ®Google Scholar
• Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A 2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem. 2004;279(47):48968–48975. doi:10.1074/jbc.M407841200
   PubMed Web of Science ®Google Scholar
• Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem. 2004;279(45):47066–47075. doi:10.1074/jbc.M403855200
   PubMed Web of Science ®Google Scholar
• Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ. Characterization of the human patatin-like phospholipase family. J Lipid Res. 2006;47(9):1940–1949. doi:10.1194/jlr.M600185-JLR200
   PubMed Web of Science ®Google Scholar
• Girousse A, Langin D. Adipocyte lipases and lipid droplet-associated proteins: insight from transgenic mouse models. Int J Obes (Lond). 2012;36(4):581–594. doi:10.1038/ijo.2011.113
   PubMedGoogle Scholar
• Bezaire V, Langin D. Regulation of adipose tissue lipolysis revisited. Proc Nutr Soc. 2009;68(4):350–360. doi:10.1017/S0029665109990279
   PubMed Web of Science ®Google Scholar
• Smirnova E, Goldberg EB, Makarova KS, Lin L, Brown WJ, Jackson CL. ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells. EMBO Rep. 2006;7(1):106–113. doi:10.1038/sj.embor.7400559
   PubMed Web of Science ®Google Scholar
• Tang T, Abbott MJ, Ahmadian M, Lopes AB, Wang Y, Sul HS. Desnutrin/ATGL activates PPARdelta to promote mitochondrial function for insulin secretion in islet beta cells. Cell Metab. 2013;18(6):883–895. doi:10.1016/j.cmet.2013.10.012
   PubMedGoogle Scholar
• Haemmerle G, Zimmermann R, Hayn M, et al. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem. 2002;277(7):4806–4815. doi:10.1074/jbc.M110355200
   PubMed Web of Science ®Google Scholar
• Wang SP, Laurin N, Himms-Hagen J, et al. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res. 2001;9(2):119–128. doi:10.1038/oby.2001.15
   PubMedGoogle Scholar
• Zechner R, Zimmermann R, Eichmann TO, et al. FAT SIGNALS–lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012;15(3):279–291. doi:10.1016/j.cmet.2011.12.018
   PubMed Web of Science ®Google Scholar
• Lucas S, Tavernier G, Tiraby C, Mairal A, Langin D. Expression of human hormone-sensitive lipase in white adipose tissue of transgenic mice increases lipase activity but does not enhance in vitro lipolysis. J Lipid Res. 2003;44(1):154–163. doi:10.1194/jlr.M200250-JLR200
   PubMedGoogle Scholar
• Vaughan M. The production and release of glycerol by adipose tissue incubated in vitro. J Biol Chem. 1962;237:3354–3358.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem. 1997;272(43):27218–27223. doi:10.1074/jbc.272.43.27218
   PubMedGoogle Scholar
• Taschler U, Radner FP, Heier C, et al. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J Biol Chem. 2011;286(20):17467–17477. doi:10.1074/jbc.M110.215434
   PubMed Web of Science ®Google Scholar
• Cota D, Marsicano G, Tschop M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest. 2003;112(3):423–431. doi:10.1172/JCI17725
   PubMed Web of Science ®Google Scholar
• Festuccia WT, Laplante M, Berthiaume M, Gelinas Y, Deshaies Y. PPARγ agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia. 2006;49(10):2427–2436. doi:10.1007/s00125-006-0336-y
   PubMedGoogle Scholar
• Brasaemle DL. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 2007;48(12):2547–2559. doi:10.1194/jlr.R700014-JLR200
   PubMed Web of Science ®Google Scholar
• Choi YH, Park S, Hockman S, et al. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest. 2006;116(12):3240–3251. doi:10.1172/JCI24867
   PubMed Web of Science ®Google Scholar
• Chakrabarti P, Kandror KV. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J Biol Chem. 2009;284(20):13296–13300. doi:10.1074/jbc.C800241200
   PubMed Web of Science ®Google Scholar
• Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol. 2007;293(1):G1–G4. doi:10.1152/ajpgi.00554.2006
   PubMedGoogle Scholar
• Dhalla AK, Chisholm JW, Reaven GM, Belardinelli L. A1 adenosine receptor: role in diabetes and obesity. Handb Exp Pharmacol. 2009;193:271–295.
   PubMedGoogle Scholar
• Jaworski K, Ahmadian M, Duncan RE, et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med. 2009;15(2):159–168. doi:10.1038/nm.1904
   PubMedGoogle Scholar
• Lafontan M. Advances in adipose tissue metabolism. Int J Obes (Lond). 2008;32(Suppl 7):S39–S51. doi:10.1038/ijo.2008.237
   PubMedGoogle Scholar
• Engel F, WhIte J. Some hormonal influences on fat mobilization from adipose tissue. Am J Clin Nutr. 1960;8(5):691–704. doi:10.1093/ajcn/8.5.691
   Google Scholar
• Lafontan M. Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol. 2005;45:119–146. doi:10.1146/annurev.pharmtox.45.120403.095843
   PubMed Web of Science ®Google Scholar
• Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab. 2005;19(4):471–482. doi:10.1016/j.beem.2005.07.004
   PubMedGoogle Scholar
• Choi SM, Tucker DF, Gross DN, et al. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol Cell Biol. 2010;30(21):5009–5020. doi:10.1128/MCB.00797-10
   PubMed Web of Science ®Google Scholar
• DiPilato LM, Ahmad F, Harms M, Seale P, Manganiello V, Birnbaum MJ. The role of PDE3B phosphorylation in the inhibition of lipolysis by insulin. Mol Cell Biol. 2015;35(16):2752–2760. doi:10.1128/MCB.00422-15
   PubMed Web of Science ®Google Scholar
• Mei J, Holst LS, Landstrom TR, et al. C(2)-ceramide influences the expression and insulin-mediated regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 adipocytes. Diabetes. 2002;51(3):631–637. doi:10.2337/diabetes.51.3.631
   PubMedGoogle Scholar
• Scherer T, O’Hare J, Diggs-Andrews K, et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 2011;13(2):183–194. doi:10.1016/j.cmet.2011.01.008
   PubMedGoogle Scholar
• Shin AC, Filatova N, Lindtner C, et al. Insulin receptor signaling in POMC, but not AgRP, neurons controls adipose tissue insulin action. Diabetes. 2017;66(6):1560–1571. doi:10.2337/db16-1238
   PubMed Web of Science ®Google Scholar
• Iwen KA, Scherer T, Heni M, et al. Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans. J Clin Endocrinol Metab. 2014;99(2):E246–E251. doi:10.1210/jc.2013-3169
   PubMedGoogle Scholar
• Xia W, Pessentheiner AR, Hofer DC, et al. Loss of ABHD15 impairs the anti-lipolytic action of insulin by altering PDE3B stability and contributes to insulin resistance. Cell Rep. 2018;23(7):1948–1961. doi:10.1016/j.celrep.2018.04.055
   PubMedGoogle Scholar
• Ragolia L, Begum N. Protein phosphatase-1 and insulin action. Mol Cell Biochem. 1998;182(1–2):49–58. doi:10.1023/A:1006827227162
   PubMed Web of Science ®Google Scholar
• Geetha T, Langlais P, Caruso M, Yi Z. Protein phosphatase 1 regulatory subunit 12A and catalytic subunit delta, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway. J Endocrinol. 2012;214(3):437–443. doi:10.1530/JOE-12-0145
   PubMedGoogle Scholar
• Koren S, DiPilato LM, Emmett MJ, et al. The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo. Diabetologia. 2015;58(5):1063–1070. doi:10.1007/s00125-015-3532-9
   PubMedGoogle Scholar
• Sun C, Jiang L, Liu Y, et al. Adipose snail1 regulates lipolysis and lipid partitioning by suppressing adipose triacylglycerol lipase expression. Cell Rep. 2016;17(8):2015–2027. doi:10.1016/j.celrep.2016.10.070
   PubMedGoogle Scholar
• Bu Y, Okunishi K, Yogosawa S, et al. Insulin regulates lipolysis and fat mass by upregulating growth/differentiation factor 3 in adipose tissue macrophages. Diabetes. 2018;67(9):1761–1772.
   PubMedGoogle Scholar
• Viscarra JA, Wang Y, Hong IH, Sul HS. Transcriptional activation of lipogenesis by insulin requires phosphorylation of MED17 by CK2. Sci Signaling. 2017;10(467):eaai8596.
   PubMedGoogle Scholar
• Chakrabarti P, English T, Shi J, Smas CM, Kandror KV. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes. 2010;59(4):775–781. doi:10.2337/db09-1602
   PubMed Web of Science ®Google Scholar
• Chakrabarti P, Kim JY, Singh M, et al. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol. 2013;33(18):3659–3666. doi:10.1128/MCB.01584-12
   PubMed Web of Science ®Google Scholar
• Bhathena SJ, Avigan J, Schreiner ME. Effect of insulin on sterol and fatty acid synthesis and hydroxymethylglutaryl CoA reductase activity in mammalian cells grown in culture. Proc Natl Acad Sci U S A. 1974;71(6):2174–2178. doi:10.1073/pnas.71.6.2174
   PubMedGoogle Scholar
• Stansbie D, Brownsey RW, Crettaz M, Denton RM. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J. 1976;160(2):413–416. doi:10.1042/bj1600413
   PubMedGoogle Scholar
• Holland R, Hardie DG. Both insulin and epidermal growth factor stimulate fatty acid synthesis and increase phosphorylation of acetyl-CoA carboxylase and ATP-citrate lyase in isolated hepatocytes. FEBS Lett. 1985;181(2):308–312. doi:10.1016/0014-5793(85)80282-9
   PubMedGoogle Scholar
• Campbell PJ, Carlson MG, Hill JO, Nurjhan N. Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Am J Physiol. 1992;263(6):E1063–E1069. doi:10.1152/ajpendo.2006.263.6.E1063
   PubMedGoogle Scholar
• Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res. 2009;48(5):275–297. doi:10.1016/j.plipres.2009.05.001
   PubMed Web of Science ®Google Scholar
• Scherer T, Lindtner C, Zielinski E, O’Hare J, Filatova N, Buettner C. Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J Biol Chem. 2012;287(39):33061–33069. doi:10.1074/jbc.M111.307348
   PubMedGoogle Scholar
• Girousse A, Tavernier G, Valle C, et al. Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol. 2013;11(2):e1001485. doi:10.1371/journal.pbio.1001485
   PubMed Web of Science ®Google Scholar
• Conte C, Fabbrini E, Kars M, Mittendorfer B, Patterson BW, Klein S. Multiorgan insulin sensitivity in lean and obese subjects. Diabetes Care. 2012;35(6):1316–1321. doi:10.2337/dc11-1951
   PubMedGoogle Scholar
• Dahlman I, Ryden M, Arner P. Family history of diabetes is associated with enhanced adipose lipolysis: evidence for the implication of epigenetic factors. Diabetes Metab. 2018;44(2):155–159. doi:10.1016/j.diabet.2017.10.010
   PubMedGoogle Scholar
• Ryden M, Hrydziuszko O, Mileti E, et al. The adipose transcriptional response to insulin is determined by obesity, not insulin sensitivity. Cell Rep. 2016;16(9):2317–2326. doi:10.1016/j.celrep.2016.07.070
   PubMedGoogle Scholar
• Wu L, Xu D, Zhou L, et al. Rab8a-AS160-MSS4 regulatory circuit controls lipid droplet fusion and growth. Dev Cell. 2014;30(4):378–393. doi:10.1016/j.devcel.2014.07.005
   PubMedGoogle Scholar
• Grahn TH, Kaur R, Yin J, et al. Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes. J Biol Chem. 2014;289(17):12029–12039. doi:10.1074/jbc.M113.539890
   PubMedGoogle Scholar
• Langin D, Dicker A, Tavernier G, et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes. 2005;54(11):3190–3197. doi:10.2337/diabetes.54.11.3190
   PubMed Web of Science ®Google Scholar
• Yan H, Pierce JR, Myers KB, et al. Exercise effects on adipose tissue postprandial lipolysis and blood flow in children. Med Sci Sports Exerc. 2018;50(6):1249–1257. doi:10.1249/MSS.0000000000001566
   PubMedGoogle Scholar
• Kim JY, Nasr A, Tfayli H, Bacha F, Michaliszyn SF, Arslanian S. Increased lipolysis, diminished adipose tissue insulin sensitivity, and impaired beta-cell function relative to adipose tissue insulin sensitivity in obese youth with impaired glucose tolerance. Diabetes. 2017;66(12):3085–3090. doi:10.2337/db17-0551
   PubMedGoogle Scholar
• Wueest S, Item F, Lucchini FC, et al. Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance. Diabetes. 2016;65(1):140–148. doi:10.2337/db15-0941
   PubMedGoogle Scholar
• Kuang J, Zhang Y, Liu Q, et al. Fat-specific Sirt6 ablation sensitizes mice to high-fat diet-induced obesity and insulin resistance by inhibiting lipolysis. Diabetes. 2017;66(5):1159–1171. doi:10.2337/db16-1225
   PubMedGoogle Scholar
• Ryden M, Petrus P, Andersson DP, et al. Insulin action is severely impaired in adipocytes of apparently healthy overweight and obese subjects. J Intern Med. 2019;285(5):578–588.
   PubMedGoogle Scholar
• Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol. 2001;11(11):437–441. doi:10.1016/S0962-8924(01)02129-8
   PubMed Web of Science ®Google Scholar
• Zick Y. Role of Ser/Thr kinases in the uncoupling of insulin signaling. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S56–S60. doi:10.1038/sj.ijo.0802503
   PubMedGoogle Scholar
• Samad F, Yamamoto K, Pandey M, Loskutoff DJ. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med. 1997;3(1):37–48. doi:10.1007/BF03401666
   PubMed Web of Science ®Google Scholar
• Samad F, Uysal KT, Wiesbrock SM, Pandey M, Hotamisligil GS, Loskutoff DJ. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A. 1999;96(12):6902–6907. doi:10.1073/pnas.96.12.6902
   PubMedGoogle Scholar
• Alessi MC, Bastelica D, Morange P, et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes. 2000;49(8):1374–1380. doi:10.2337/diabetes.49.8.1374
   PubMed Web of Science ®Google Scholar
• Fain JN, Tichansky DS, Madan AK. Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism. 2005;54(11):1546–1551. doi:10.1016/j.metabol.2005.05.024
   PubMedGoogle Scholar
• Lin Y, Nakachi K, Ito Y, et al. Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults. Dis Markers. 2009;27(1):23–28. doi:10.1155/2009/529253
   PubMedGoogle Scholar
• Yadav H, Quijano C, Kamaraju AK, et al. Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab. 2011;14(1):67–79. doi:10.1016/j.cmet.2011.04.013
   PubMed Web of Science ®Google Scholar
• Jacobsson B, Smith U. Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells. J Lipid Res. 1972;13(5):651–656.
   PubMedGoogle Scholar
• Olefsky JM. Effects of fasting on insulin binding, glucose transport, and glucose oxidation in isolated rat adipocytes: relationships between insulin receptors and insulin action. J Clin Invest. 1976;58(6):1450–1460. doi:10.1172/JCI108601
   PubMedGoogle Scholar
• Smith U. Effect of cell size on lipid synthesis by human adipose tissue in vitro. J Lipid Res. 1971;12(1):65–70.
   PubMedGoogle Scholar
• Qiang G, Whang Kong H, Xu S, et al. Lipodystrophy and severe metabolic dysfunction in mice with adipose tissue-specific insulin receptor ablation. Mol Metab. 2016;5(7):480–490. doi:10.1016/j.molmet.2016.05.005
   PubMedGoogle Scholar
• Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta. 2009;1791(6):507–513. doi:10.1016/j.bbalip.2008.12.014
   PubMed Web of Science ®Google Scholar
• Bodis K, Roden M. Energy metabolism of white adipose tissue and insulin resistance in humans. Eur J Clin Invest. 2018;48(11):e13017.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yu M, Arshad M, et al. Coordination among lipid droplets, peroxisomes, and mitochondria regulates energy expenditure through the CIDE-ATGL-PPARalpha pathway in adipocytes. Diabetes. 2018;67(10):1935–1948. doi:10.2337/db17-1452
   PubMedGoogle Scholar
• Wei S, Liu S, Su X, et al. Spontaneous development of hepatosteatosis in perilipin-1 null mice with adipose tissue dysfunction. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(2):212–218. doi:10.1016/j.bbalip.2017.11.007
   PubMedGoogle Scholar
• Brown RJ, Valencia A, Startzell M, et al. Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy. J Clin Invest. 2018;128(8):3504–3516. doi:10.1172/JCI95476
   PubMed Web of Science ®Google Scholar
• Zhao S, Zhu Y, Schultz RD, et al. Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab. 2019;30(4):706–719 e706. doi:10.1016/j.cmet.2019.08.005
   PubMed Web of Science ®Google Scholar
• Gavrilova O, Marcus-Samuels B, Reitman ML. Lack of responses to a beta3-adrenergic agonist in lipoatrophic A-ZIP/F-1 mice. Diabetes. 2000;49(11):1910–1916. doi:10.2337/diabetes.49.11.1910
   PubMedGoogle Scholar
• Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 1996;10(9):1096–1107. doi:10.1101/gad.10.9.1096
   PubMed Web of Science ®Google Scholar
• Shimomura I, Hammer RE, Richardson JA, et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 1998;12(20):3182–3194. doi:10.1101/gad.12.20.3182
   PubMed Web of Science ®Google Scholar
• Li FX, Li JL, Rong XL, et al. Study on mouse model characterized by insulin resistance- fatty liver and hypercholesteremia induced by lipodystrophy. Tradit Chin Drug Res Clin Pharmacol. 2014;25(1):96–101.
   Google Scholar
• Vegiopoulos A, Rohm M, Herzig S. Adipose tissue: between the extremes. EMBO J. 2017;36(14):1999–2017. doi:10.15252/embj.201696206
   PubMed Web of Science ®Google Scholar
• Desai KS, Li KC, Angel A. Bimodal effect of insulin on hormone-stimulated lipolysis: relation to intracellular 3ʹ,5ʹ-cyclic adenylic acid and free fatty acid levels. J Lipid Res. 1973;14(6):647–655.
   PubMedGoogle Scholar
• Mooney RA, Ebersohl RD, McDonald JM. Insulin-mediated antilipolysis in permeabilized rat adipocytes. J Biol Chem. 1984;259(12):7701–7704.
   PubMedGoogle Scholar
• Lavis VR, Williams RH. Lipolytic effects of high concentrations of insulin on isolated fat cells. Enhancement of the response to lipolytic hormones. Diabetes. 1973;22(8):629–636. doi:10.2337/diab.22.8.629
   PubMedGoogle Scholar
• Strålfors P, Jönsson C, Batista A, Kjölhede P. Insulin and β-adrenergic receptors mediate lipolytic and anti-lipolytic signalling that is not altered by type 2 diabetes in human adipocytes. Biochem J. 2019;476(19):2883–2908. doi:10.1042/BCJ20190594
   PubMedGoogle Scholar
• Bourron O, Daval M, Hainault I, et al. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia. 2010;53(4):768–778. doi:10.1007/s00125-009-1639-6
   PubMed Web of Science ®Google Scholar
• He J, Xu C, Kuang J, et al. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance. Metabolism. 2015;64(7):826–836. doi:10.1016/j.metabol.2015.02.005
   PubMedGoogle Scholar
• Hodis J, Vaclavíková R, Farghali H. Beta-3 agonist-induced lipolysis and nitric oxide production: relationship to PPARgamma agonist/antagonist and AMP kinase modulation. Gen Physiol Biophys. 2011;30(1):90–99. doi:10.4149/gpb_2011_01_90
   PubMedGoogle Scholar
• Hasan AU, Ohmori K, Hashimoto T, et al. PPARγ activation mitigates glucocorticoid receptor-induced excessive lipolysis in adipocytes via homeostatic crosstalk. J Cell Biochem. 2018;119(6):4627–4635. doi:10.1002/jcb.26631
   PubMedGoogle Scholar
• Gastaldelli A, Casolaro A, Ciociaro D, et al. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2009;297(1):E225–E230. doi:10.1152/ajpendo.90960.2008
   PubMedGoogle Scholar
• Krag MB, Nielsen S, Guo Z, et al. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity. Clin Endocrinol (Oxf). 2008;69(3):452–461. doi:10.1111/j.1365-2265.2008.03231.x
   PubMedGoogle Scholar
• Zhao W, Li A, Feng X, et al. Metformin and resveratrol ameliorate muscle insulin resistance through preventing lipolysis and inflammation in hypoxic adipose tissue. Cell Signal. 2016;28(9):1401–1411. doi:10.1016/j.cellsig.2016.06.018
   PubMed Web of Science ®Google Scholar
• Zhang T, He J, Xu C, et al. Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes. J Mol Endocrinol. 2009;42(1):57–66. doi:10.1677/JME-08-0130
   PubMedGoogle Scholar
• Arner P, Andersson DP, Backdahl J, Dahlman I, Ryden M. Weight gain and impaired glucose metabolism in women are predicted by inefficient subcutaneous fat cell lipolysis. Cell Metab. 2018;28(1):45–54.e43. doi:10.1016/j.cmet.2018.05.004
   PubMedGoogle Scholar
• Mayer N, Schweiger M, Romauch M, et al. Development of small-molecule inhibitors targeting adipose triglyceride lipase. Nat Chem Biol. 2013;9(12):785–787. doi:10.1038/nchembio.1359
   PubMedGoogle Scholar